IL3RA and neoplasm: Furthermore, TECs generated EVs by blocking IL‐3Rα or depleting miR‐24‐3p, which could also effectively inhibit angiogenesis and impede primary tumour metastasis by upregulating sprouty RTK signalling antagonist 2 (SPRY2) in TNBC [65].